Status:
COMPLETED
Circulating Levels of Pealbumin in Relation to Overweight or Obesity
Lead Sponsor:
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Conditions:
Obesity
Eligibility:
All Genders
Brief Summary
The study was aimed to investigating the relationship between circulating level of prealbumin and parathormone (PTH), triglycerides and triiodothyronine (FT3) in overweight and obese subjects (BMI≥25 ...
Eligibility Criteria
Inclusion
- Overweight or obesity (BMI\> 25 Kg/m2)
Exclusion
- Any kind of drug Hypertension Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), Chronic inflammatory diseases Renal failure Liver failure Angina pectoris Myocardial infarction and heart failure Genetic heart diseases Thrombocytopenias
Key Trial Info
Start Date :
January 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04333446
Start Date
January 7 2019
End Date
December 31 2019
Last Update
May 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luisa Lampignano
Castellana Grotte, Italy, 70013